How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer
Background: The role of real-world evidence (RWE) in the development of anticancer therapies has been gradually growing over time. Regulators, payers and health technology assessment agencies, spurred by the rise of the precision medicine model, are increasingly incorporating RWE into their decision...
Saved in:
Main Authors: | Robbe Saesen (Author), Georgios Kantidakis (Author), Ann Marinus (Author), Denis Lacombe (Author), Isabelle Huys (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
by: Stefanie Broes, et al.
Published: (2021) -
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
by: Robbe Saesen, et al.
Published: (2020) -
Patients' knowledge, preferences, and perspectives about data protection and data control: an exploratory survey
by: Teodora Lalova-Spinks, et al.
Published: (2024) -
Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom
by: Alexandre Pérez-López, et al.
Published: (2020) -
Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders
by: M Dooms, et al.
Published: (2022)